Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


10.07.2017

1 Ann Surg Oncol
6 Anticancer Res
4 BMC Cancer
1 Br J Cancer
4 Breast Cancer (Dove Med Press)
2 Breast Cancer Res
9 Breast Cancer Res Treat
1 Breast J
1 Cancer
3 Clin Cancer Res
1 Eur Radiol
2 Gene
1 Histopathology
5 Int J Cancer
1 Int J Oncol
1 J Biol Chem
2 J Clin Oncol
1 J Surg Oncol
1 Lancet Oncol
1 Nat Rev Cancer
1 Nature
2 NPJ Breast Cancer
1 Oncol Rep
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. AJMANI GS, James TA, Kantor O, Wang CH, et al
    The Impact of Facility Volume on Rates for Pathologic Complete Response to Neoadjuvant Chemotherapy Used in Breast Cancer.
    Ann Surg Oncol. 2017 Jul 6. doi: 10.1245/s10434-017-5969.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. ALCANTARA DZ, Soliman IJS, Pobre RF, Naguib RNG, et al
    Effects of Pulsed Electromagnetic Fields on Breast Cancer Cell Line MCF 7 Using Absorption Spectroscopy.
    Anticancer Res. 2017;37:3453-3459.
    PubMed     Text format     Abstract available

  3. REMO M, Abraham I, Kankanala V, Chacra W, et al
    Hepatitis B Reactivation in a Patient Receiving Chemotherapy for Breast Cancer: A Case Report.
    Anticancer Res. 2017;37:3791-3793.
    PubMed     Text format     Abstract available

  4. CHIRICO A, D'Aiuto G, Penon A, Mallia L, et al
    Self-Efficacy for Coping with Cancer Enhances the Effect of Reiki Treatments During the Pre-Surgery Phase of Breast Cancer Patients.
    Anticancer Res. 2017;37:3657-3665.
    PubMed     Text format     Abstract available

  5. ORFANIDOU T, Xanthopoulos K, Dafou D, Pseftogas A, et al
    Down-regulation of the Tumor Suppressor CYLD Enhances the Transformed Phenotype of Human Breast Cancer Cells.
    Anticancer Res. 2017;37:3493-3503.
    PubMed     Text format     Abstract available

  6. HU T, Su F, Jiang W, Dart DA, et al
    Overexpression of Activin Receptor-like Kinase 7 in Breast Cancer Cells Is Associated with Decreased Cell Growth and Adhesion.
    Anticancer Res. 2017;37:3441-3451.
    PubMed     Text format     Abstract available

  7. MESCHER C, Ding C, Defor T, Konety S, et al
    Left Ventricular Ejection Fraction Screening and Clinical Decision-making in Metastatic HER2-positive Breast Cancer.
    Anticancer Res. 2017;37:3751-3755.
    PubMed     Text format     Abstract available


    BMC Cancer

  8. LANGIUS-EKLOF A, Crafoord MT, Christiansen M, Fjell M, et al
    Effects of an interactive mHealth innovation for early detection of patient-reported symptom distress with focus on participatory care: protocol for a study based on prospective, randomised, controlled trials in patients with prostate and breast cance
    BMC Cancer. 2017;17:466.
    PubMed     Text format     Abstract available

  9. VAN ROOZENDAAL LM, Vane MLG, van Dalen T, van der Hage JA, et al
    Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08).
    BMC Cancer. 2017;17:459.
    PubMed     Text format     Abstract available

  10. STEFANSSON OA, Hermanowicz S, van der Horst J, Hilmarsdottir H, et al
    CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer.
    BMC Cancer. 2017;17:469.
    PubMed     Text format     Abstract available

  11. ROININEN N, Takala S, Haapasaari KM, Jukkola-Vuorinen A, et al
    Primary neuroendocrine breast carcinomas are associated with poor local control despite favourable biological profile: a retrospective clinical study.
    BMC Cancer. 2017;17:72.
    PubMed     Text format     Abstract available


    Br J Cancer

  12. WU J, Zhou XJ, Sun X, Xia TS, et al
    RBM38 is involved in TGF-beta-induced epithelial-to-mesenchymal transition by stabilising zonula occludens-1 mRNA in breast cancer.
    Br J Cancer. 2017 Jul 6. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Breast Cancer (Dove Med Press)

  13. JOHNSON R, Sabnis N, Sun X, Ahluwalia R, et al
    SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer.
    Breast Cancer (Dove Med Press). 2017;9:383-392.
    PubMed     Text format     Abstract available

  14. HOU Y, Zhou M, Xie J, Chao P, et al
    High glucose levels promote the proliferation of breast cancer cells through GTPases.
    Breast Cancer (Dove Med Press). 2017;9:429-436.
    PubMed     Text format     Abstract available

  15. DELOU JMA, Vignal GM, Indio-do-Brasil V, Accioly MTS, et al
    Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis.
    Breast Cancer (Dove Med Press). 2017;9:415-428.
    PubMed     Text format     Abstract available

  16. EL CHEDIAK A, Alameddine RS, Hakim A, Hilal L, et al
    Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: analysis of a prospective cohort.
    Breast Cancer (Dove Med Press). 2017;9:407-414.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  17. BROUWERS B, Fumagalli D, Brohee S, Hatse S, et al
    The footprint of the ageing stroma in older patients with breast cancer.
    Breast Cancer Res. 2017;19:78.
    PubMed     Text format     Abstract available

  18. SHENOUDA MM, Gillgrass A, Nham T, Hogg R, et al
    Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours.
    Breast Cancer Res. 2017;19:76.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  19. ROSSO KJ, Ueno NT, Woodward WA, Lucci A, et al
    In response to "outcomes of patients with inflammatory breast cancer treated by breast conserving surgery": the argument against breast conservation and sentinel lymph node biopsy in IBC.
    Breast Cancer Res Treat. 2017 Jul 3. doi: 10.1007/s10549-017-4337.
    PubMed     Text format    

  20. COSTA R, Santa-Maria CA, Scholtens DM, Jain S, et al
    A pilot study of cabergoline for the treatment of metastatic breast cancer.
    Breast Cancer Res Treat. 2017 Jul 3. doi: 10.1007/s10549-017-4370.
    PubMed     Text format     Abstract available

  21. VRIENS BEPJ, Vriens IJH, Aarts MJB, van Gastel SM, et al
    Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer.
    Breast Cancer Res Treat. 2017 Jul 3. doi: 10.1007/s10549-017-4364.
    PubMed     Text format     Abstract available

  22. EHLERS DK, Aguinaga S, Cosman J, Severson J, et al
    The effects of physical activity and fatigue on cognitive performance in breast cancer survivors.
    Breast Cancer Res Treat. 2017 Jul 4. doi: 10.1007/s10549-017-4363.
    PubMed     Text format     Abstract available

  23. HURTZ HJ, Tesch H, Gohler T, Hutzschenreuter U, et al
    Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project.
    Breast Cancer Res Treat. 2017 Jul 5. doi: 10.1007/s10549-017-4365.
    PubMed     Text format     Abstract available

  24. RUGO HS, Tredan O, Ro J, Morales SM, et al
    A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer.
    Breast Cancer Res Treat. 2017 Jul 5. doi: 10.1007/s10549-017-4375.
    PubMed     Text format     Abstract available

  25. BUNDRED NJ, Thomas J, Dixon JMJ
    Whither surgical quality assurance of breast cancer surgery (surgical margins and local recurrence) after paterson.
    Breast Cancer Res Treat. 2017 Jul 5. doi: 10.1007/s10549-017-4369.
    PubMed     Text format     Abstract available

  26. MARINE G, Alexandra K, Stephanie G, Sebastien H, et al
    Pro-apoptotic effect of Delta2-TGZ in "claudin-1-low" triple-negative breast cancer cells: involvement of claudin-1.
    Breast Cancer Res Treat. 2017 Jul 5. doi: 10.1007/s10549-017-4378.
    PubMed     Text format     Abstract available

  27. GEURTS YM, Witteveen A, Bretveld R, Poortmans PM, et al
    Patterns and predictors of first and subsequent recurrence in women with early breast cancer.
    Breast Cancer Res Treat. 2017 Jul 4. doi: 10.1007/s10549-017-4340.
    PubMed     Text format     Abstract available


    Breast J

  28. WOLLSCHLAGER D, Meng X, Wockel A, Janni W, et al
    Comorbidity-dependent adherence to guidelines and survival in breast cancer-Is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients.
    Breast J. 2017 Jul 7. doi: 10.1111/tbj.12855.
    PubMed     Text format     Abstract available


    Cancer

  29. POWIS M, Sutradhar R, Gonzalez A, Enright KA, et al
    Establishing achievable benchmarks for quality improvement in systemic therapy for early-stage breast cancer.
    Cancer. 2017 Jul 5. doi: 10.1002/cncr.30804.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  30. UEDA S, Saeki T, Osaki A, Yamane T, et al
    Bevacizumab induces acute hypoxia and cancer progression in patients with refractory breast cancer: Multimodal functional imaging and multiplex cytokine analysis.
    Clin Cancer Res. 2017 Jul 5. pii: clincanres.0874.2017.
    PubMed     Text format     Abstract available

  31. RIETHDORF S, Muller V, Loibl S, Nekljudova V, et al
    Prognostic impact of circulating tumor cells for breast cancer patients treated in the neoadjuvant "Geparquattro" trial.
    Clin Cancer Res. 2017 Jul 5. pii: clincanres.0255.2017.
    PubMed     Text format     Abstract available

  32. MA CX, Bose R, Gao F, Freedman RA, et al
    Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Non-amplified Metastatic Breast Cancer.
    Clin Cancer Res. 2017 Jul 5. pii: clincanres.0900.2017.
    PubMed     Text format     Abstract available


    Eur Radiol

  33. WIENBECK S, Uhlig J, Luftner-Nagel S, Zapf A, et al
    The role of cone-beam breast-CT for breast cancer detection relative to breast density.
    Eur Radiol. 2017 Jul 4. doi: 10.1007/s00330-017-4911.
    PubMed     Text format     Abstract available


    Gene

  34. ZHOU J, Hang D, Jiang Y, Chen J, et al
    Evaluation of genetic variants in autophagy pathway genes as prognostic biomarkers for breast cancer.
    Gene. 2017 Jun 29. pii: S0378-1119(17)30503-6. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available

  35. YELKEN BO, Balci T, Susluer SY, Kayabasi C, et al
    The effect of tomatine on metastasis related matrix metalloproteinase (MMP) activities in breast cancer cell model.
    Gene. 2017 Jun 29. pii: S0378-1119(17)30505-X. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    Histopathology

  36. HOLTEN-ROSSING H, Talman MM, Jylling AMB, Laenkholm AV, et al
    Application of automated image analysis reduces the workload of manual screening of sentinel Lymph node biopsies in breast cancer.
    Histopathology. 2017 Jul 5. doi: 10.1111/his.13305.
    PubMed     Text format     Abstract available


    Int J Cancer

  37. SCHIROSI L, De Summa S, Tommasi S, Paradiso A, et al
    VEGF and TWIST1 in a 16-biomarker immunoprofile useful for prognosis of breast cancer patients.
    Int J Cancer. 2017 Jul 5. doi: 10.1002/ijc.30868.
    PubMed     Text format     Abstract available

  38. SANKATSING VDV, van Ravesteyn NT, Heijnsdijk EAM, de Koning HJ, et al
    Reply to Letter to Editor: 'Questionable method for estimating the influence of mammography screening on breast cancer mortality in the Netherlands.'
    Int J Cancer. 2017 Jul 6. doi: 10.1002/ijc.30873.
    PubMed     Text format    

  39. SANDSVEDEN M, Manjer J
    Selenium and breast cancer risk: A prospective nested case-control study on serum selenium levels, smoking habits and overweight.
    Int J Cancer. 2017 Jul 6. doi: 10.1002/ijc.30875.
    PubMed     Text format     Abstract available

  40. AUTIER P, Boniol M
    Questionable method for estimating the influence of mammography screening on breast cancer mortality in the Netherlands.
    Int J Cancer. 2017 Jul 6. doi: 10.1002/ijc.30874.
    PubMed     Text format    

  41. BARRDAHL M, Rudolph A, Hopper JL, Southey MC, et al
    Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30859.
    PubMed     Text format     Abstract available


    Int J Oncol

  42. LI SJ, Liu CS, Li HJ, Li Y, et al
    A novel engineered interferon-alpha hybrid molecule increases anticancer efficacy of doxorubicin in breast cancer chemotherapy.
    Int J Oncol. 2017 Jul 3. doi: 10.3892/ijo.2017.4062.
    PubMed     Text format     Abstract available


    J Biol Chem

  43. SANDERS MA, Haynes B, Nangia-Makker P, Polin LA, et al
    Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
    J Biol Chem. 2017;292:10347-10363.
    PubMed     Text format     Abstract available


    J Clin Oncol

  44. HARBECK N, Gluz O, Christgen M, Kates RE, et al
    De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and The
    J Clin Oncol. 2017 Jul 6:JCO2016719815. doi: 10.1200/JCO.2016.71.9815.
    PubMed     Text format     Abstract available

  45. ENRIGHT KA, Taback N, Powis ML, Gonzalez A, et al
    Setting Quality Improvement Priorities for Women Receiving Systemic Therapy for Early-Stage Breast Cancer by Using Population-Level Administrative Data.
    J Clin Oncol. 2017 Jul 6:JCO2016707950. doi: 10.1200/JCO.2016.70.7950.
    PubMed     Text format     Abstract available


    J Surg Oncol

  46. HAGE AN, Capriccioso C, Brennan J, Heiden B, et al
    Impact of neoadjuvant chemotherapy on surgical outcomes among patients with hormone receptor positive breast cancer.
    J Surg Oncol. 2017 Jul 3. doi: 10.1002/jso.24721.
    PubMed     Text format     Abstract available


    Lancet Oncol

  47. MATHEW A, Brufsky A
    TACT2: improving treatment tolerability in early breast cancer.
    Lancet Oncol. 2017;18:843-845.
    PubMed     Text format    


    Nat Rev Cancer

  48. LIEBEN L
    Immunotherapy: Keeping breast cancer in check.
    Nat Rev Cancer. 2017 Jul 7. doi: 10.1038/nrc.2017.
    PubMed     Text format    


    Nature

  49. YE X, Brabletz T, Kang Y, Longmore GD, et al
    Upholding a role for EMT in breast cancer metastasis.
    Nature. 2017;547:E1-E3.
    PubMed     Text format    


    NPJ Breast Cancer

  50. CHEN YH, Hancock BA, Solzak JP, Brinza D, et al
    Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.
    NPJ Breast Cancer. 2017;3:24.
    PubMed     Text format     Abstract available

  51. MAETENS M, Brown D, Irrthum A, Aftimos P, et al
    The AURORA pilot study for molecular screening of patients with advanced breast cancer-a study of the breast international group.
    NPJ Breast Cancer. 2017;3:23.
    PubMed     Text format     Abstract available


    Oncol Rep

  52. ZHONG J, Chen YJ, Chen L, Shen YY, et al
    PRMT2beta, a C-terminal splice variant of PRMT2, inhibits the growth of breast cancer cells.
    Oncol Rep. 2017 Jul 3. doi: 10.3892/or.2017.5786.
    PubMed     Text format     Abstract available


    PLoS One

  53. JI W, Wang B, Fan Q, Xu C, et al
    Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy.
    PLoS One. 2017;12:e0180037.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  54. LIU T, Zhang H, Sun L, Zhao D, et al
    FSIP1 binds HER2 directly to regulate breast cancer growth and invasiveness.
    Proc Natl Acad Sci U S A. 2017 Jul 3. pii: 201621486.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: